B P3 C20 Cardiac Computed Tomography Flashcards

1
Q

Non–contrast-enhanced ECG gated study during a single cardiac phase used to identify the presence and amount of calcified coronary plaque.

A

Coronary artery calcium (CAC) scan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Contrast-enhanced ECG gated study performed to identify the presence and amount of both calcified and noncalcified plaque, and to estimate the severity of luminal stenosis.

A

CCTA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Contrast ECG gated images to evaluate various pathologies ranging from valvular heart disease and cardiac function to cardiac masses and pulmonary venous anatomy.

A

Cardiac CT to evaluate noncoronary structures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Amount of CAC classified as moderate

A

Moderate - 100 - 299

The overall amount of coronary plaque can then be categorized as:

Absent (CAC = 0)
Minimal (1 to 9)
Mild (10 to 99)
Moderate (100 to 299)
Severe (300 to 999)
Extreme (≥1000)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Calcifications in the coronary arteries indicate the presence of coronary atherosclerosis, and there is a direct association between the ______________ in both men and women,and across different races.

A

Amount of coronary calcifications and long-term risk of future cardiovascular events

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The absence of coronary calcifications (i.e., CAC score of zero) has been shown to be associated with a ____________ event rate, especially among individuals with a 10-year ASCVD risk that is <20%.

A

Very low 10 year event rate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In addition to being a strong predictor of CHD events, increased CAC can also be used to predict other forms of cardiovascular disease (CVD), including _______

A

Atrial fibrillation, stroke, and congestive heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

The current 2018 AHA/ACC multisociety cholesterol guideline states that in _________ or __________, if the decision about statin use remains uncertain, it is reasonable to use CAC testing in the decision to withhold, postpone, or initiate statin therapy

A

Intermediate-risk or selected borderline-risk adults (i.e., 10-year ASCVD risk of 5%–20%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When CAC testing is used in this context, if the CAC score is zero, it is reasonable to ___________ and __________, as long as higher risk conditions are absent (diabetes mellitus, family history of premature CHD, cigarette smoking).

A

Withhold statin therapy

Reassess in 5 to 10 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

The AHA/ACC guidelines indicate that if the CAC score is 1 to 99, it is reasonable to initiate statin therapy, especially in those __________

A

≥55 years of age

If the CAC score is 100 or higher or in the 75th percentile or higher, it is recommended to initiate statin therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In patients with severe CAC and when there is uncertainty regarding patient symptoms or exercise capacity, ________ may be reasonable.

A

Exercise testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

When further testing is considered, ________ may be particularly beneficial

A

Positron emission tomography myocardial perfusion imaging (PET MPI)

Because?

Normal myocardial blood flow reserve can be used to exclude high-risk anatomy and inform prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_______ should not be performed in asymptomatic individuals with severe CAC.

A

Invasive angiography

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Is repeat CAC testing useful to assess response to statin therapy?

A

No

The amount of CAC cannot be reduced with therapy, in fact, some studies have shown that statin therapy may be associated with a mild increase in CAC progression. Nevertheless, the strong association of CAC with future cardiovascular events is robust in patients who are on lipid-lowering therapies.

Repeat CAC testing is not useful to assess response to therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

________ has the highest sensitivity of any noninvasive imaging technique to detect the presence of anatomic stenosis.

A

CCTA

Sensitivity of 97% (93 to 99) with a specificity of 78% (67 to 86) for detecting >50% stenosis.

When evaluating the diagnostic accuracy of CCTA to detect functionally significant coronary artery disease (CAD), as defined by an invasive fractional flow reserve (FFR) ≤0.80, the sensitivity of CCTA was 93% (89 to 96) with a specificity of 53% (37 to 68).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In this trial, CCTA had the highest diagnostic accuracy to detect significant CAD, defined by invasive angiography as >50% stenosis of the left main stem, >70% stenosis in a major coronary vessel, or 30% to 70% stenosis with FFR ≤0.8. The sensitivity of CCTA was 91% (86 to 95), whereas the specificity was 92% (89% to 95%).

A

EVINCI (Evaluation of Integrated Cardiac Imaging for the D tion and Characterization of Ischemic Heart Disease) study

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

In this study, CCTA (90%) and PET (87%) had the highest s sitivity, whereas PET and SPECT had the highest specificity. The overall diagnostic accuracy to detect lesion-specific ischemia was highest for PET.

A

PACIFIC trial (Prospective Comparison of Cardiac PET/CT, SPECT/ CT Perfusion Imaging and CT Coronary Angiography With Invasive Coronary Angiography)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

The overall risk of major CVD events increased in a stepwise manner with both atherosclerotic disease burden (determined by the total CAC score) and number of vessels with ≥50% stenosis.

When stratified by groups of increasing CAC, patients with nonobstructive CAD had a risk of CVD events similar to those with obstructive CAD, suggesting that _________, not stenosis, was the main predictor of future CVD events.

A

Plaque burden

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

CCTA as an alternative to invasive angiography to exclude ACS when there is ___________ and when cardiac troponin and/or ECG are normal or inconclusive.

A

Low-to-intermediate likelihood of CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Patients who are ideal candidates for CCTA have

A

No known CAD
Can achieve a low heart rate (e.g., <70 beats/min with medications)
Can hold their breath during image acquisition
Can tolerate the administration of IV contrast

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

In this trial, patients randomized to standard care plus CCTA or to standard care alone

Over a median follow-up of 4.8 years, the addition of CCTA to standard of care resulted in a 41% reduction in the combined endpoint of CHD death or nonfatal MI

A

SCOT-HEART trial

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

The _________ trial compared a strategy of CCTA versus functional testing

Although there was no difference in this primary outcome, the use of CCTA was associated with a lower rate of death or MI at 12 months (HR 0.66; P = 0.049).

A

PROMISE trial

The use of CCTA was associated with a lower incidence of invasive angiography showing no obstructive CAD during the 90 days after randomization

However, more patients in the CCTA group underwent invasive angiography within 90 days of randomization (12.2% vs. 8.1%) and more patients in the CCTA group underwent coronary revascularization (6.2% vs. 3.2%).

Patients with diabetes who underwent CCTA had a lower risk of cardiovascular death or MI compared with those who were randomized to functional stress testing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

The mechanisms underlying improved patient outcomes in the use of CCTA include

A

The use of CCTA was associated with greater use of preventive therapies such as statins and aspirin.

The observed reduction in events observed in this trial was explained by modeling, which accounted for the benefits of medical therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

_______ on CCTA (Hounsfield units [HU] <30) corresponds to lipid-rich plaque; more often seen in patients with ACS, and has been found to be associated with ruptured fibrous caps,75 lesion-specific ischemia, 76and a future risk of MI

A

Low-attenuation plaque

Noncalcified plaque with higher CT attenuation correlates with fibrous tissues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

___________ compensatory enlargement of the vessel wall as plaque size increases outward to preserve the luminal area.

This feature is associated with a larger burden of plaque, a larger necrotic core, and also higher likelihood of thin-cap fibroatheroma (TCFA) by intravascular ultrasound (IVUS).

A

Positive remodeling

A remodeling index threshold of ≥1.1 is typically used to define positive remodeling

Remodeling index is calculated as the vessel cross-sec area at the site of maximal stenosis divided by the average of the proximal and distal reference segments’ crosssectional areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Plaques that on cross-section have a ring-like peripheral enhancement surrounding low CT attenuation in the center

The central area of low attenuation represents, based on pathologic correlation, a large necrotic core,

A

Napkin-ring sign

Plaques with the NRS contain large necrotic cores and, although infrequent, they have a higher association with future events than other APCs.

27
Q

_____defined as small, dense (>130 HU) plaque components surrounded by noncalcified plaque tissue.

A

Spotty clacifications

Compared with intermediate (1 to 3 mm) calcifications, small (<1 mm) spotty calcification have the strongest association with HRP features defined by virtual histology IVUS, and may represent plaques that are more likely to accelerate.

Weaker marker of future risk compared with other APCs, such as low-attenuation plaque and positive remodeling.

28
Q

Number of coronary segments with plaque, which can provide an estimate of the overall extent of plaque which can provide incremental prognostic value

A

Segment involvement score

29
Q

On rest CCTA images, a resting perfusion defect (i.e._____________ ) can be used to identify areas of prior infarction or high-grade stenosis.

Other features of a prior infarction on CCTA include

A

Subendocardial hypoenhancement of the myocardium

Areas of fatty metaplasia, intramyocardial calcifications
Wall thinning
Wall motion abnormalities

30
Q

The advantage of CT FFR is that it provides __________, and thus may help inform revascularization decisions.

A

Lesion-specific ischemia

31
Q

FFRCT may aid decision making in lesions that have _______ (i.e., 40% to 70%) in the proximal or mid-coronary vessel

A

Intermediate stenosis

32
Q

The value of stress CT perfusion is greatest when ________, where CT perfusion can increase the specificity of anatomic stenosis measures to detect myocardial ischemia.

A

Added to the CCTA data

33
Q

CT perfusion can also be performed in patients who have __________, and it is generally less dependent on high image quality than CCTA, as it does not require high spatial resolution

A

Significant coronary calcification and stents

34
Q

The ____________ trial found that among stable patients who had evidence of moderate to severe ischemia on stress testing, an initial invasive strategy, when compared with an initial conservative strategy, was not associated with a reduction in the primary outcome of cardiovascular death, MI, hospitalization for unstable angina, hospitalization for heart failure, or resuscitated cardiac arrest over a median follow-up of 3.3 years.

A

ISCHEMIA trial

In this trial, CCTA was useful for excluding left main disease (∼5%) or nonobstructive CAD (∼14%)

35
Q

Class 1 indications for CCTA in patients presenting with ST segment elevation (ESC 2020 ACS Guidelines)

A

CCTA is recommended as an alternative to invasive angiography to exclude ACS when there is a low-to-intermediate likelihood of CAD and when cardiac troponin and/or ECG are normal or inconclusive (Class 1, Level A)

In patients with no recurrence of chest pain, normal ECG findings, and normal levels of cardiac troponin (preferably high sensitivity), but still with a suspected ACS, a noninvasive stress test (preferably with imaging) for inducible ischemia or CCTA is recommended before deciding on an invasive approach (Class 1, Level B)

36
Q

Class 1 indications for CCTA in patients presenting with acute chest pain (2021 ACC/AHA Guideline for Chest Pain)

A

For intermediate-risk patients with acute chest pain and no known coronary artery disease eligible for diagnostic testing following a negative or inconclusive evaluation for acute coronary syndrome, CCTA is useful for exclusion of atherosclerotic plaque and obstructive coronary artery disease

37
Q

Class 1 indications for CCTA in patients presenting with stable chest pain (2021 ACC/AHA Guideline for Chest Pain)

A

For intermediate–high risk patients with stable chest pain and no known coronary artery disease, CCTA is effective for diagnosis of CAD, for risk stratification, and for guiding treatment decisions. (Class 1, Level A)

38
Q

Most patients only require preventive therapies following CCTA, and invasive angiography should be reserved for patients that have ________, or those with obstructive CAD with __________

A

High-risk anatomy (e.g., left main stenosis or three-vessel obstructive CAD)

Frequent or unstable symptoms.

39
Q

Recommendations for a normal CCTA (CAD-RADS 0)

A

Preventive lifestyle therapies should be the main focus

Patients who have no plaque or stenosis should be reassured that they have an excellent prognosis,

40
Q

Recommendations for nonobstructive plaque (CAD-RADS 1 or 2)/Patients with minimal (1% to 24%) or mid (25% to 49%)

A

Evaluation for potential nonatherosclerotic causes of their symptoms

In select cases of mild (25% to 49%) stenosis in which there is a large amount of diffuse plaque or HRP features, a noninvasive evaluation for ischemia can be considered, if there are frequent symptoms and a high suspicion for ongoing ischemia

Focus on lifestyle and pharmacologic preventive therapies

41
Q

Risk level of atherosclerosis can be determined based on the

A

Amount or extent of plaque (e.g., number of segments or vessels that have coronary plaque and CAC score, if available)
Presence of HRP features plaque progression
Lesion location
Extent of obstructive CAD

42
Q

Risk level of atherosclerosis can be determined based on the

A

Amount or extent of plaque (e.g., number of segments or vessels that have coronary plaque and CAC score, if available)
Presence of HRP features plaque progression
Lesion location
Extent of obstructive CAD

43
Q

Recommendations for Moderate stenosis (50% to 69%; CAD-RADS 3)

A

Lifestyle and pharmacologic preventive therapies

Functional assessment may be considered if there are frequent symptoms.

Routine invasive angiography should be avoided unless there are frequent or unstable symptoms.

44
Q

Recommendations for Severe stenosis (70% to 99%; CAD-RADS 3).

A

Lifestyle and pharmacologic preventive therapies

Functional assessment or invasive angiography may be considered if there are frequent symptoms.

In the presence of left main disease or three-vessel obstructive (≥70%) CAD, invasive angiography is recommended.

45
Q

Recommendations for Total occlusion (100%; CAD-RADS 4)

A

Invasive angiography and/or viability assessment should be considered

46
Q

Routine CCTA in ________ who are on baseline preventive therapies has not been shown to improve patient outcomes

A

Asymptomatic individuals

47
Q

The use of CCTA among __________ may be associated with improved outcomes when compared with functional testing approaches.

A

Symptomatic patients with diabetes

48
Q

CCTA is also the only noninvasive test that can be used to detect ___________

A

Spontaneous coronary artery dissection

Although women are less likely to have obstructive CAD than men, CCTA allows for the accurate detection of nonobstructive plaque, including overall plaque extent, and HRP features. CCTA has similar accuracy and prognostic value in men and women,

49
Q

CCTA is a useful noninvasive test used to evaluate patients with known or suspected anomalous origin of the coronary arteries

In general, vessels with a ______________ are considered benign

A

Retroaortic or prepulmonic course

50
Q

Highest risk of sudden death is attributed when there is an anomalous __________

A

Left main coronary artery arising from the right cusp with an interarterial course

Patients who have a right coronary artery arising from the left cusp with an interarterial course, or those with a subpulmonic (also known as transseptal) left main arising from the right cusp have a variable level of risk and require a careful assessment

51
Q

CCTA derived features that were associated with subsequent revascularization of anomalous coronaries included

A

Slit-like narrowing of the origin
Interarterial course
Intramural course
arrowing of proximal anomalous vessel of >5.4 mm in length

52
Q

CCTA has been shown to be highly accurate for detecting stenosis in __________

A

Arterial or venous bypass grafts

53
Q

Cardiac CT has emerged as a useful test to evaluate various forms of valvular heart disease.

Although all four cardiac valves can be assessed when a multiphase acquisition is performed, imaging of the ________ is more challenging,

A

Tricuspid valve

54
Q

The severity of aortic stenosis can be determined by calculating the Agatston calcium score of the aortic valve, in which a measure _______ in men and _________ in women has been found to provide good discriminatory value for diagnosing severe aortic stenosis, and identifying patients with adverse prognosis.

A

Men >2065
Women >1274

55
Q

One particular advantage of cardiac CT is the ability to evaluate patients with ____________

A

Mechanical valves

56
Q

When there is suspicion for valve d function, cardiac CT can evaluate for valvular ________ and _______

In native valves, cardiac CT can detect ________ with a high diagnostic accuracy, although very small vegetations can be challenging to detect.

In prosthetic valves, cardiac CT can identify paravalvular lesions, such as ____________.

A

Thrombosis and pannus
Vegetations
Pseudoaneurysm, abscess, or fistula

57
Q

There are various forms of myocardial and infiltrative heart disease that can be identified on routine cardiac CT.

Images at end diastole can be used to measure left and right ventricular wall thickness, and left and right ventricular size.

_________ on CT refers to the acquisition of images ∼8 minutes after contrast administration

A

Late enhancement imaging

58
Q

Identify

A

Sinus venosus defect

59
Q

Identify

A

Anomalous pulmonary venous return

60
Q

Identify

A

Atrial septal defect

61
Q

Identify

A

Patent foramen ovale

62
Q

Identify

A

Ventricular septal defect

63
Q

Features of leaflet thrombosis on cardiac CT include _______ and reduced leaflet motion, also referred to as _______

A

Hypoattenuated leaflet thickening (HALT)

Hypoattenuation affecting motion (HAM)

64
Q

Parameters in the aortic root assessment during TAVR

A

Aortic annulus
Landing zone calcium
Valve mirphology
Coronary ostial height and sinus of Valsalva assessment
Aprtic root measurements
Optimal fluoroscopic angles